Ovarian endometrioma: surveillance or surgery, and impact on fertility

Medically reviewed on 6 August 2026 - Dr. Senai Aksoy
Ovarian endometrioma: surveillance or surgery, and impact on fertility

Key Takeaways

An endometrioma (ovarian endometriosis cyst, sometimes called a 'chocolate cyst') has a characteristic 'ground-glass' ultrasound appearance. The choice between surveillance and surgery depends on size, clinical impact, fertility plans and any signs of atypia.

Key evidence: ESHRE Guideline: Endometriosis (2022) Effect of Endometrioma Excision on Ovarian Reserve: Meta-Analysis

On this page

What is an endometrioma?

An endometrioma is an ovarian cyst filled with old, degraded blood. It develops from endometrial-like tissue growing within the ovary.

It is also commonly called a “chocolate cyst”.

On transvaginal ultrasound, it often has a classic “ground-glass” appearance. The cyst has homogeneous, finely granular echoes without solid vascularised components.

Key features of endometriomas include:

Ultrasound features

Ultrasound evaluation confirms cyst characteristics and excludes other ovarian pathology.

Typical sonographic signs include:

The differential diagnosis includes functional haemorrhagic cysts, dermoid cysts, and ovarian malignancy.

Functional haemorrhagic cysts often resolve within 6 to 8 weeks.

Surveillance or surgery?

Clinical management balances symptom relief and diagnostic clarity against possible damage to ovarian reserve.

Indications for Surveillance

Indications for Surgery

Warning signs of malignancy

The overall risk of malignant transformation remains low. Endometriomas have a small association with clear-cell and endometrioid ovarian carcinomas.

Key ultrasound warning signs requiring specialist review:

Any suspicious features mandate a pelvic MRI and immediate gynecologic oncology consultation.

Impact of cystectomy on ovarian reserve

Surgical removal of an endometrioma wall is called cystectomy. It can remove some surrounding healthy ovarian tissue.

Thermal injury can also occur during haemostasis.

Key findings on surgical impact:

Before IVF: no routine surgery

ESHRE 2022 guidelines issue a strong recommendation against routine cystectomy prior to IVF.

Evidence from the Hamdan et al. (2015) meta-analysis confirms:

Surgery before IVF is reserved exclusively for severe pain, suspected malignancy, or large cysts preventing safe follicle aspiration.

Fertility preservation before surgery

If surgery is required in a young patient, fertility preservation must be evaluated prior to the operation.

Key preservation options:

Targeting 15 to 20 mature oocytes provides a realistic foundation for future pregnancy options.

Surgical techniques: sparing reserve

When surgery is unavoidable, ovarian-sparing techniques reduce tissue loss:

Recurrence after surgery

Without post-operative medical suppression, endometrioma recurrence reaches 21.5% at 2 years. It reaches 30% to 50% at 5 years.

Bilateral endometrioma: major caution

Bilateral endometriomas require extra precaution due to heightened surgical risks:

Clinical Note

I advise caution before operating on an endometrioma in a patient planning pregnancy or IVF.

Cystectomy removes the cyst capsule, but it can also remove adjacent normal ovarian tissue and reduce ovarian reserve.

Surgery should be reserved for severe pain, large cysts blocking follicle access during retrieval, or any suspicion of atypia.

Dr. Senai Aksoy

In practice

FAQ

Should every endometrioma be operated?

No. An asymptomatic unilateral endometrioma under 4 cm with typical ultrasound features in a woman with fertility plans can be monitored. Surgery is indicated for refractory pain, suspected malignancy, a large cyst obstructing follicle access, or complications.

Will my AMH drop after surgery?

Likely yes. On average, cystectomy reduces AMH by about 30% after unilateral surgery and 44% after bilateral surgery.

Part of this drop may also reflect the biological effect of the cyst itself on the ovary.

Should I have my endometrioma removed before IVF?

Not automatically. Studies do not show improved live birth after pre-IVF cystectomy. The discussion centres on pain, follicle access at retrieval and any suspicion of malignancy.

For how long should I monitor an endometrioma?

As long as the surveillance criteria hold, monitoring can continue. These criteria include stable size under 4 cm, no atypia, no disabling pain, and preserved ovarian reserve.

Ultrasounds every 6 to 12 months are generally enough. The interval should reflect the clinical course and fertility plans.

Can my endometrioma become cancer?

The risk of ovarian cancer is slightly increased in women with endometriosis, especially for clear-cell and endometrioid carcinomas. It remains low in absolute terms.

Ultrasound signs of atypia include papillary projections, thick septations, solid components, and atypical vascularity. These findings warrant specialist review and complementary MRI.

Should I freeze my eggs before surgery?

To be discussed with your team based on your age, current reserve, uni- or bilateral nature, and fertility plans. Preservation is particularly relevant before a bilateral cystectomy or in a young woman without an ongoing pregnancy plan.

What helps limit recurrence after surgery?

Maintenance hormonal therapy significantly reduces endometrioma recurrence after surgery. Options include continuous combined contraceptives, dienogest, or a levonorgestrel-releasing IUS for women without immediate pregnancy plans.

Sources

Next step

A question about your own case?

An article can set out the general picture, but not what applies to your own history. If you would like your situation looked at, you can send your questions and any previous reports to the medical team.

For privacy, please send only information needed for an initial reply. Ask the team which secure channel to use for medical reports or identity documents.

Request a medical review

Add as a Preferred Source on Google

You can add draksoyivf.com as one of your preferred health information sources on Google.

Add on Google
Dr. Senai Aksoy

Dr. Senai Aksoy studied and trained in France before returning to Turkey, where he was a founding member of the ICSI team at Sevgi Hospital, Ankara — the country's first ICSI centre (1994-95) — and a co-author on the first Turkish ICSI publications produced in collaboration with the Brussels Van Steirteghem group (Human Reproduction, 1996; PMID 8671323). He helped build the IVF programme at the American Hospital Istanbul and has been running his own fertility practice since 1998.

Verified profiles: PubMed ORCID LinkedIn

The content has been created by Dr. Senai Aksoy and medically approved.